Cargando…

1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19

BACKGROUND: Convalescent plasma (CP) may be obtained from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. Although not FDA approved, preliminary data suggests patients who receive convalescent plasma from recovered donors may have shortened r...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyner, Nancy M, Deaney, Michael, Derrick, Caroline, Bouchard, Jeannette, Brown, Hannah G, Freeman, Kennedy J, Drummond, Malashia, Harper, Madeline, Waddell, Alexandria, Albrecht, Helmut, Weissman, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776494/
http://dx.doi.org/10.1093/ofid/ofaa439.1312
_version_ 1783630696962588672
author Joyner, Nancy M
Deaney, Michael
Derrick, Caroline
Bouchard, Jeannette
Brown, Hannah G
Freeman, Kennedy J
Drummond, Malashia
Harper, Madeline
Waddell, Alexandria
Albrecht, Helmut
Weissman, Sharon
author_facet Joyner, Nancy M
Deaney, Michael
Derrick, Caroline
Bouchard, Jeannette
Brown, Hannah G
Freeman, Kennedy J
Drummond, Malashia
Harper, Madeline
Waddell, Alexandria
Albrecht, Helmut
Weissman, Sharon
author_sort Joyner, Nancy M
collection PubMed
description BACKGROUND: Convalescent plasma (CP) may be obtained from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. Although not FDA approved, preliminary data suggests patients who receive convalescent plasma from recovered donors may have shortened recovery time and symptom reduction. The purpose of the study is to detail learner recruitment of convalescent plasma donation (CPD) for treating hospitalized COVID-19 patients. METHODS: Prisma Health Midlands formed a multidisciplinary CP donation team, consisting of seven COVID-19-certified pharmacy learner volunteers, two pharmacists, and two providers. Primary eligibility criteria were SARS-CoV-2 polymerase chain reaction (PCR) positivity at least 28 days prior to donation and asymptomatic for a minimum of 14 days. Donors were excluded based on FDA guidelines for CPD, limiting ineligible contact. Team learners were trained on call techniques and subsequently contacted, educated, and requested candidates donate through this program. Willing donors were then linked to The Blood Connection to circulate CP back into the Prisma Health System, creating a self-sustaining and closed-loop donation cycle. RESULTS: In total, 253 recovered adult patients with positive SARS-CoV-2 PCR test results were evaluated. 195 patients met baseline inclusion criteria for contact. This pre-screen reduced call and travel time for ineligible candidates. 108 patients were successfully reached. Of the 108, n=79 (73.14%) accepted referral to The Blood Connection, and n=29 (26.85%) were no longer candidates primarily due to patient communicated new exclusionary factors, such as active COVID-19 symptoms. The program allowed for rapid, internal access to CP for patients hospitalized with COVID-19 at Prisma Health Midlands. CONCLUSION: Interest and awareness in COVID-19 CPD was successfully increased upon direct communication from the team and was felt to represent a personnel intense but successful model for recruiting potential CP donors. This program educated and utilized learners during this pandemic to enhance Prisma Health’s ability to obtain CP for hospitalized patients using a closed system. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776494
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77764942021-01-07 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19 Joyner, Nancy M Deaney, Michael Derrick, Caroline Bouchard, Jeannette Brown, Hannah G Freeman, Kennedy J Drummond, Malashia Harper, Madeline Waddell, Alexandria Albrecht, Helmut Weissman, Sharon Open Forum Infect Dis Poster Abstracts BACKGROUND: Convalescent plasma (CP) may be obtained from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. Although not FDA approved, preliminary data suggests patients who receive convalescent plasma from recovered donors may have shortened recovery time and symptom reduction. The purpose of the study is to detail learner recruitment of convalescent plasma donation (CPD) for treating hospitalized COVID-19 patients. METHODS: Prisma Health Midlands formed a multidisciplinary CP donation team, consisting of seven COVID-19-certified pharmacy learner volunteers, two pharmacists, and two providers. Primary eligibility criteria were SARS-CoV-2 polymerase chain reaction (PCR) positivity at least 28 days prior to donation and asymptomatic for a minimum of 14 days. Donors were excluded based on FDA guidelines for CPD, limiting ineligible contact. Team learners were trained on call techniques and subsequently contacted, educated, and requested candidates donate through this program. Willing donors were then linked to The Blood Connection to circulate CP back into the Prisma Health System, creating a self-sustaining and closed-loop donation cycle. RESULTS: In total, 253 recovered adult patients with positive SARS-CoV-2 PCR test results were evaluated. 195 patients met baseline inclusion criteria for contact. This pre-screen reduced call and travel time for ineligible candidates. 108 patients were successfully reached. Of the 108, n=79 (73.14%) accepted referral to The Blood Connection, and n=29 (26.85%) were no longer candidates primarily due to patient communicated new exclusionary factors, such as active COVID-19 symptoms. The program allowed for rapid, internal access to CP for patients hospitalized with COVID-19 at Prisma Health Midlands. CONCLUSION: Interest and awareness in COVID-19 CPD was successfully increased upon direct communication from the team and was felt to represent a personnel intense but successful model for recruiting potential CP donors. This program educated and utilized learners during this pandemic to enhance Prisma Health’s ability to obtain CP for hospitalized patients using a closed system. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776494/ http://dx.doi.org/10.1093/ofid/ofaa439.1312 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Joyner, Nancy M
Deaney, Michael
Derrick, Caroline
Bouchard, Jeannette
Brown, Hannah G
Freeman, Kennedy J
Drummond, Malashia
Harper, Madeline
Waddell, Alexandria
Albrecht, Helmut
Weissman, Sharon
1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title_full 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title_fullStr 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title_full_unstemmed 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title_short 1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
title_sort 1126. learner driven call center to increase convalescent plasma donation in covid-19
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776494/
http://dx.doi.org/10.1093/ofid/ofaa439.1312
work_keys_str_mv AT joynernancym 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT deaneymichael 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT derrickcaroline 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT bouchardjeannette 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT brownhannahg 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT freemankennedyj 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT drummondmalashia 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT harpermadeline 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT waddellalexandria 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT albrechthelmut 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19
AT weissmansharon 1126learnerdrivencallcentertoincreaseconvalescentplasmadonationincovid19